Independent forecasts built on public federal data. Not a U.S. government website.

WE PHARMA, INC.

WE PHARMA, INC. has won 17 federal awards worth $5.4M in total across 1 agencies, with a median award of $250K. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.

17
awards won
$5.4M
total obligated
$250K
median award
1
agencies

Recent awards

TitleAgencyValueDate
PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLDepartment Of Health And Human Services$300K2025-09-16
TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDDepartment Of Health And Human Services$607K2025-07-28
PHARMACEUTICAL DRUG PRODUCTSDepartment Of Health And Human Services$75K2025-05-14
PHARMACEUTICAL DRUG PRODUCT ORDERSDepartment Of Health And Human Services$400K2023-07-31
PHARMACEUTICAL PRODUCTS FOR FDA/OPQ DOMESTIC MANUFACTURING AND REGULATDepartment Of Health And Human Services$240K2023-03-23

Questions

How many federal contracts has WE PHARMA, INC. won?

17 awards on record, worth $5.4M in total across 1 agency. The median award is $250K.

Which agencies buy from WE PHARMA, INC.?

Mostly Department Of Health And Human Services.

Is WE PHARMA, INC. a competitor worth watching?

That depends on your category. This page lists the agencies they win from and their recent awards, so you can see whether they are active in the lanes you bid. AwardCast forecasts the closing price for a specific open solicitation, which is the number that matters when you are bidding against them.

Agencies they win from

12 more awards + the price forecast for any solicitation this contractor is bidding.

Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.

Every forecast is scored against the real award once it becomes public. See the track record.

Get a forecast — $49

$49 per report. No subscription, no account needed to see pricing.